Stock TRML TOURMALINE BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Tourmaline Bio, Inc.

Equities

TRML

US89157D1054

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-18 pm EDT 		5-day change 1st Jan Change
15.55 USD +3.39% Intraday chart for Tourmaline Bio, Inc. -0.45% -40.60%
May. 16 Tourmaline Bio, Inc Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial CI
May. 13 Tourmaline Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Chart calendar Tourmaline Bio, Inc.

2d1af3b6d881e07c02b883979cfdaeb5.f1msvSswQPjHYWSgRZMl2xtB2UjiNwnVVcm7i-o-kbQ.OzPI8l9xL6fxLx7JIMZNrnI7oQmnRUyfEoLa4r5VvMMcLdmMcnwUqvQGVA~269da8d6307b9bfc2657961064084fcf

Upcoming events on Tourmaline Bio, Inc.

No events available

Past events on Tourmaline Bio, Inc.

2024-06-06 02:30 pm Jefferies Global Healthcare Conference
2024-05-20 04:00 pm H.C. Wainwright BioConnect Investor Conference
2024-05-13 07:00 am Q1 2024 Earnings Release
2024-04-10 01:00 pm Piper Sandler Cardio Day
2024-03-19 07:00 am Q4 2023 Earnings Release
2024-03-13 10:00 am Leerink Partners Global Biopharma Conference
2024-03-11 Jefferies Biotech on the Bay Summit
2024-02-07 11:00 am Guggenheim Healthcare Talks Biotechnology Conference
2023-06-13 09:00 am Annual General Meeting
2022-11-29 04:20 pm Evercore ISI HealthCONx Conference
2022-11-10 07:00 am Q3 2022 Earnings Release
2022-11-05 05:51 pm American Society of Nephrology Meeting - Absract Number: SA-OR50
2022-11-05 05:33 pm American Society of Nephrology Meeting - Absract Number: SA-OR48
2022-10-10 Cell & Gene Meeting - Pre-recorded
2022-09-28 01:00 pm William Blair Innovations In Solid Organ And Hematopoietic Stem Cell Transplant Virtual Conference
2022-09-14 09:00 am H.C. Wainwright Global Investment Conference
2022-09-12 01:40 pm Morgan Stanley Global Healthcare Conference
2022-08-15 07:00 am Interim 2022 Earnings Release
2022-06-30 08:00 am American Transplant Congress
2022-06-09 01:00 pm Annual General Meeting

Annual results

Fiscal PeriodDecember 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		0,00


-45,4
-53,1
14.46%
-80,1

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-42,1
-55,1
23.53%
-78,1

Net income
Million USD		Released
Forecast
Spread 		-19,7


-42,1
-56,0
24.82%
-73,3

EPS
USD		Released
Forecast
Spread 		-1,79


-8,87
-4,15
-113.94%
-2,99

Announcement Date20/07/2319/03/24-

Quarterly results

Fiscal PeriodDecember 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-8,93
-14,4
37.76%		-14,9
-13,8
-7.86%		-17,5
-15,8
-10.97%
-19,4


-20,7


-22,6


-20,3


-22,0

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-7,02
-14,4
51.12%		-12,9
-15,8
18.55%		-13,3
-15,7
15.09%
-19,8


-21,1


-24,2


-20,3


-22,0

Net income
Million USD		Released
Forecast
Spread 		-7,02
-14,4
51.12%		-12,9
-15,8
18.36%		-13,3
-15,0
11.41%
-18,4


-19,4


-21,6


-20,3


-22,0

EPS
USD		Released
Forecast
Spread 		-1,64
-0,71
-132.62%		-0,81
-0,77
-5.19%		-0,55
-0,67
17.66%
-0,72


-0,76


-0,84


-0,83


-0,90

Announcement Date14/11/2319/03/2413/05/24-----

Upcoming sector events for Tourmaline Bio, Inc.

2024-07-23 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 am ARGENX SE: Q2 2024 Earnings Release
2024-07-29 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Tourmaline Bio, Inc.

2024-06-05 03:51 am PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
2024-05-17 07:00 am AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 am BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
2024-05-15 08:05 am THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 am CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
2024-05-14 04:05 pm ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 04:00 pm ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. TRML Stock
  4. Calendar Tourmaline Bio, Inc.